
Opinion|Videos|March 26, 2024
Treatment Sequencing and Combination Therapies for MM
Carol Ann Huff, MD discusses how the approval of additional bispecific antibodies for multiple myeloma might change the treatment selection process, highlighting considerations for sequencing of agents and combination therapy.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Multifaceted Approach to Navigating Career Transitions in Pharmacy
2
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
3
First FDA-Approved Oral Liquid Sitagliptin for Adults with Type 2 Diabetes
4
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
5















































































































































































































